EXIT-SITE DRESSING AND INFECTION IN PERITONEAL DIALYSIS: A RANDOMIZED CONTROLLED PILOT TRIAL

被引:18
|
作者
Mushahar, Lily [1 ]
Mei, Lim Wei [1 ]
Yusuf, Wan Shaariah [1 ]
Sivathasan, Sudhaharan [1 ]
Kamaruddin, Norilah [1 ]
Idzham, Nor Juliana Mohd [1 ]
机构
[1] Hosp Tuanku Jaafar, Dept Nephrol, Seremban, Negeri Sembilan, Malaysia
来源
PERITONEAL DIALYSIS INTERNATIONAL | 2016年 / 36卷 / 02期
关键词
Dressings; exit-site infection; tunnel infection; peritonitis; CATHETER-RELATED INFECTIONS; STAPHYLOCOCCUS-AUREUS; MUPIROCIN; PREVENTION; PROPHYLAXIS; OINTMENT; CREAM; CAPD; CARE;
D O I
10.3747/pdi.2014.00195
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: Peritoneal dialysis (PD)-related infection is a common cause of catheter loss and the main reason for PD drop-out. Exit-site infection (ESI) is a pathway to developing tunnel infection and peritonitis, hence rigorous exit-site care has always been emphasized in PD therapy. The aim of this study was to evaluate the effect of exit-site dressing vs non-dressing on the rate of PD-related infection. Methods: A prospective randomized controlled study was conducted in prevalent PD patients at the Hospital Tuanku Jaafar Seremban, Negeri Sembilan, Malaysia, from April 2011 until April 2013. All patients were required to perform daily washing of the exit site with antibacterial soap during a shower. In the dressing group (n = 54), patients were required to clean their exit site using povidone-iodine after drying, followed by topical mupirocin antibiotic application to the exit site. The exit site was then covered with a sterile gauze dressing and the catheter immobilized with tape. In the non-dressing group (n = 54), patients were not required to do any further dressing after drying. They were only required to apply mupirocin cream to the exit site and then left the exit site uncovered. The catheter was immobilized with tape. The primary outcome was ESI. The secondary outcomes were evidence of tunnel infection or peritonitis. Results: A total of 97 patients completed the study. There were a total of 12 ESI episodes: 4 episodes in 4 patients in the dressing group vs 8 episodes in 4 patients in the non-dressing group. This corresponds to 1 episode per 241.3 patient-months vs 1 episode per 111.1 patient-months in the dressing and non-dressing groups respectively. Median time to first ESI episode was shorter in the non-dressing than in the dressing group, but not significant (p = 0.25). The incidence of gram-positive ESI in both groups was similar. There were no gram-negative ESI in the non-dressing group compared with 2 in the dressing group. The peritonitis rate was 1 per 37.1 patient-month in the dressing group and 1 per 44.4 patient-months in the non-dressing group. Median time to first peritonitis episode was significantly shorter in the dressing group compared to non-dressing (p = 0.03). There was no impact of dressing disruptions in the occurrence of major PD catheter-related infection. Conclusion: Use of a non-dressing technique with only prophylactic topical mupirocin cream application is effective in preventing PD-related infection. The non-dressing technique is more cost-effective and convenient for PD patients, with fewer disposables.
引用
收藏
页码:135 / 139
页数:5
相关论文
共 50 条
  • [41] A comparative analysis on the incidence of peritonitis and exit-site infection in CAPD and automated peritoneal dialysis
    Rodríguez-Carmona, A
    Fontán, MP
    Falcón, TG
    Rivera, CF
    Valdés, F
    PERITONEAL DIALYSIS INTERNATIONAL, 1999, 19 (03): : 253 - 258
  • [42] Effect of local mupirocin application on exit-site infection and peritonitis in peritoneal dialysis patients
    Yang, Jong-Oh
    Gil, Hyo-Wook
    Lee, Eun-Young
    Hong, Sae-Yong
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 499 - 500
  • [43] Effects of cognitive impairment and assisted peritoneal dialysis on exit-site infection in older patients
    Hiroki Yabe
    Keiko Okada
    Kenichi Kono
    Yuto Imoto
    Ayaka Onoyama
    Sayaka Ito
    Yoshifumi Moriyama
    Hirotake Kasuga
    Yasuhiko Ito
    Clinical and Experimental Nephrology, 2022, 26 : 593 - 600
  • [44] Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis
    Bending, M
    Mellotte, G
    Hashmi, C
    Coles, GA
    Morgan, JD
    Ashman, R
    Schurgers, ML
    Gordis, BZ
    DHoore, MM
    Faller, B
    Genestier, S
    Grawey, I
    Slingeneyer, A
    Laroche, B
    Ville, JL
    Winney, RJ
    Plant, WD
    Miles, RS
    Scouse, P
    Williams, P
    Moncrieff, N
    Brown, C
    Norman, P
    Nichols, N
    Rennes, JG
    Holmes, CJ
    Hudson, I
    Horton, D
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (11): : 2403 - 2408
  • [45] Prevention and management of peritonitis and exit-site infection in patients on continuous ambulatory peritoneal dialysis
    Vargemezis, V
    Thodis, E
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 : 106 - 108
  • [46] Late Peritoneal Dialysis Exit-Site Leak: A Case Report
    Horowitz, Laura
    Ashley, Justin
    Brassil, Michael
    Marcuzzi, Danny
    Perl, Jeffrey
    KIDNEY MEDICINE, 2023, 5 (07)
  • [47] EXIT-SITE INFECTION - A RANDOMIZED TRIAL ON TOPIC VS PARENTERAL THERAPY
    FELLIN, G
    GENTILE, MG
    GUERRA, L
    SCALAMOGNA, A
    MANILI, L
    CANCARINI, G
    LUPO, A
    PERITONEAL DIALYSIS INTERNATIONAL, 1988, 8 (01): : 78 - 78
  • [48] Current approach to exit-site infections in patients on peritoneal dialysis
    Twardowski, ZJ
    Prowant, BF
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (06) : 1284 - 1295
  • [49] Prevention and treatment of peritoneal catheter exit-site infection
    Montenegro, J
    NEFROLOGIA, 1999, 19 (06): : 502 - 507
  • [50] Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients
    Bernardini, J
    Bender, F
    Florio, T
    Sloand, J
    PalmMontalbano, L
    Fried, L
    Piraino, B
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (02): : 539 - 545